Interim analysis of Phase 3 clinical trial shows CoronaVac vaccine safe, effective: Lancet

Source : Xinhua

Production : China Daily, un quotidien chinois en anglais. Il fut fondé en 1981 et est le plus important des journaux en anglais du pays, avec un tirage de 200 000 exemplaires.

Diffusion : Le site China Daily (chinadaily.com.cn)

Date et heure : 9 juillet 2021, 10:58

LONDON – Interim analysis of Phase 3 clinical trial of the CoronaVac vaccine in more than 10,000 participants in Turkey suggests the efficacy of two doses of the vaccine is 83.5 percent against symptomatic cases of COVID-19, according to a study published on Thursday in The Lancet, a weekly peer-reviewed general medical journal.

Source : Xinhua, “Interim analysis of Phase 3 clinical trial shows CoronaVac vaccine safe, effective: Lancet”, China Daily, 09/07/2021. URL : https://www.chinadaily.com.cn/a/202107/09/WS60e7bb61a310efa1bd660d3a.html (consulté le 20/07/2021).

Article de référence :

Mine Durusu Tanriover, Hamdi Levent Doğanay, Murat Akova [et al.], “Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey”, The Lancet, Volume 398, Issue 10296, P213-222, 17/07/2021. (publication en ligne :08/07/2021). DOI : https://doi.org/10.1016/S0140-6736(21)01429-X :

Bihua Han, Yufei Song, Changgui Li [et al.], “Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial”, The Lancet, 28/06/2021. DOI : https://doi.org/10.1016/S1473-3099(21)00319-4 (consulté le 20/07/2021).

Yanjun Zhang, Gang Zeng, Hongxing Pan [et al.], “Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial”, The Lancet, 17/11/2020. DOI : https://doi.org/10.1016/S1473-3099(20)30843-4 (consulté le 20/07/2021).

Photo “à la une” : A staff member shows CoronaVac vaccine vials at Sinovac Life Sciences in Beijing. © Chen Xiaogen/for China Daily

---

---